Mednet Logo
HomeHematologyQuestion

What would be the main indications for opting for biosimilars over an original biologic, outside of insurance barriers?

2
2 Answers
Mednet Member
Mednet Member
Rheumatology · Arthritis and Rheumatism Associates, P.C.

A timely question, as we head to 2023! The only reason to use biosimilars is for the broad purpose of resource stewardship. There isn't a medical reason to prefer a biosimilar over a reference product (or vice versa), because if a product were found to have a significantly different therapeutic effe...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Northwestern University - The Feinberg School of Medicine

For those interested, there is an upcoming webinar by the Arthritis Foundation discussing the usage of biosimilars in inflammatory arthritis. It is on 11/9/2022, 6-7PM ET. Further details at the link below:

https://www.arthritis.org/events/webinars/upcoming-webinars

This may provide further informat...

Register or Sign In to see full answer